Historical trend of disparity implications of Medicare MTM eligibility criteria

Research in Social and Administrative Pharmacy

Volumn 9, Issue 6, 2013, Pages 758-769

  Wang, Junling ^a   Qiao, Yanru ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Eligibility criteria; Ethnicity; Health disparities; Historical trend; Medication therapy management services; Race

Indexed keywords

AFRICAN AMERICAN; AGED; ARTICLE; CAUCASIAN; ELIGIBILITY CRITERIA; ETHNICITY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE SURVEY; HEALTH DISPARITY; HISPANIC; HISTORICAL TREND; HUMAN; MALE; MEDICATION THERAPY MANAGEMENT; MEDICATION THERAPY MANAGEMENT SERVICES; ORGANIZATION AND MANAGEMENT; RACE; STATISTICS; UNITED STATES; VERY ELDERLY;

ELIGIBILITY CRITERIA; ETHNICITY; HEALTH DISPARITIES; HISTORICAL TREND; MEDICATION THERAPY MANAGEMENT SERVICES; RACE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ELIGIBILITY DETERMINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE SURVEYS; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; UNITED STATES;

EID: 84887615589     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2012.09.003     Document Type: Article

References (35)

1. Heckler MM. Report of the Secretary's Task Force on Black and Minority Health. Available at: Accessed 29.08.12. http://minorityhealth.hhs.gov/assets/pdf/checked/1/ANDERSON.pdf.
2. Koh H.K., Graham G., Glied S.A. Reducing racial and ethnic disparities: the action plan from the Department of Health and Human Services. Health Aff (Millwood) 2011, 30:1822-1829.
3. National Healthcare Disparities Report. Highlights from the National Healthcare Quality and Disparities Reports. Agency for Healthcare Research & Quality. Available at: 2011. Accessed 07.02.12. http://www.ahrq.gov/qual/nhdr11/Key.htm.
4. Blazer D.G., Hybels C.F., Fillenbaum G.G., Pieper C.F. Predictors of antidepressant use among older adults: have they changed over time?. Am J Psychiatry 2005, 162:705-710.
5. Blazer D.G., Hybels C.F., Simonsick E.M., Hanlon J.T. Marked differences in antidepressant use by race in an elderly community sample: 1986-1996. Am J Psychiatry 2000, 157:1089-1094.
6. Wang J., Noel J.M., Zuckerman I.H., Miller N.A., Shaya F.T., Mullins C.D. Disparities in access to essential new prescription drugs between non-Hispanic Whites, non-Hispanic Blacks, and Hispanic Whites. Med Care Res Rev 2006, 63:742-763.
7. Wang J., Zuckerman I.H., Miller N.A., Shaya F.T., Noel J.M., Mullins C.D. Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites. Health Serv Res 2007, 42:1499-1519.
8. Weinick R., Hasnain-Wynia R. Quality improvement efforts under health reform: how to ensure that they help reduce disparities-not increase them. Health Aff (Millwood) 2011, 30:1837-1843.
9. Woolf S.H., Braveman P. Where health disparities begin: the role of social and economic determinants-and why current policies may make matters worse. Health Aff (Millwood) 2011, 30:1852-1859.
10. Eichner J., Vladeck B.C. Medicare as a catalyst for reducing health disparities. Health Aff (Millwood) 2005, 24:365-375.
11. Neuman P., Cuibanski J. Medicare Part D update-lessons learned and unfinished business. N Engl J Med 2009, 361:406-414.
12. Centers for Medicare & Medicaid Services, and Department of Health & Human Services Medicare program; Medicare prescription drug benefit. Final rule. Fed Regist 2005, 70:4193-4585.
13. Bluml B.M. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc 2003, 45:566-572.
14. Cranor C.W., Bunting B.A., Christensen D.B. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003, 43:173-184.
15. Etemad L.R., Hay J.W. Cost-effectiveness analysis of pharmaceutical care in a Medicare drug benefit program. Value Health 2003, 6:425-435.
16. Fera T., Bluml B.M., Ellis W.M. Diabetes Ten City Challenge: final economic and clinical results. J Am Pharm Assoc 2009, 49:383-391.
17. Centers for Medicare & Medicaid Services and Department of Health & Human services. Medicare Part D Medication Therapy Management (MTM) Programs. Available at: 2011. Accessed 29.08.12. http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/downloads/MTMFactSheet2011063011Final.pdf.
18. Byrd L., Fletcher A., Menifield C. Disparities in health care: minority elders at risk. ABNF J 2007, 18:5155.
19. Wang J., Mullins C.D., Brown L.M., et al. Disparity implications of Medicare eligibility criteria for medication therapy management services. Health Serv Res 2010, 45:1061-1082.
20. Briesacher B., Limcangco R., Gaskin D. Racial and ethnic disparities in prescription coverage and medication use. Health Care Financ Rev 2003, 25:63-76.
21. Schore J., Brown R., Lavin B. Racial disparities in prescription drug use among dually eligible beneficiaries. Health Care Financ Rev 2003, 25:77-90.
22. Medical Expenditure Panel Survey 2012, Agency for Healthcare Research & Quality, Rockville, MD, Available at:, Accessed 15.03.12. http://meps.ahrq.gov/mepsweb/.
23. Centers for Medicare and Medicaid Services. Medicare Part D Medication Therapy Management (MTM) Programs: 2008 Fact Sheet. Available at: 2008. Accessed 13.04.09 (not available online anymore, available through the authors upon request). http://www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/MTMFactSheet.pdf.
24. Daniel G.W., Malone D.C. Characteristics of older adults who meet the annual prescription drug expenditure threshold for Medicare medication therapy management programs. J Manag Care Pharm 2007, 13:142-154.
25. Andersen R.M., Davidson P.L. Improving access to care in America: individual and contextual indicators. Changing the U.S. Health Care System: Key Issues in Health Services, Policy and Management 2001, 3-30. Jossey-Bass, San Francisco, CA. T. Andersen, T. Rice, G. Kominski (Eds.).
26. Edgar B.S. Shifting the focus from cost to value: a government perspective. J Manag Care Pharm 2006, 12(6suppl B):S11-S15. quiz S24-S26.
27. Centers for Disease Control & Prevention. HealthyPeople 2010 Final Review: Executive Summary. Available at: Accessed 31.08.12. http://www.cdc.gov/nchs/data/hpdata2010_final_review_executive_summary.pdf.
28. LaVeist T.A., Gaskin D., Richard P. Estimating the economic burden of racial health inequalities in the United States. Int J Health Serv 2011, 41:231-238.
29. Colorado Department of Public Health and Environment. The Cost of Health Disparities in Colorado. Available at: 2005. Accessed 10.01.11. http://www.cdphe.state.co.us/ohd/ethnicDisparitiesreport/48cost.pdf.
30. Waidmann T. Estimating the Cost of Racial and Ethnic Health Disparities. Washington: The Urban Institute. Available at: Accessed 06.03.12. http://www.urban.org/publications/411962.html.
31. Suthers K. Evaluating the Economic Causes and Consequences of Racial and Ethnic Health Disparities 2008, American Public Health Association Issue Brief, Washington.
32. Wang J., Dong Z., Hong S.H., Suda K.J. A comparison of direct medical costs across racial and ethnic groups among children with cancer. Curr Med Res Opin 2008, 24:847-858.
33. Wang J., White-Means S.I., Hufstader M.A., Walker G.D. The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors. Curr Med Res Opin 2007, 23:853-863.
34. Levy H., Weir D.R. Take-up of Medicare Part D: results from the Health and Retirement Study. J Gerontol B Psychol Sci Soc Sci 1999, 65:492-501.
35. Maciejewski M.L., Farley J.F., Hansen R.A., Wei D., Harman J.S. Part D plan enrollment by uninsured Medicare beneficiaries. Med Care 2010, 48:183-186.